in this issue
People & Business :: M&A
Novozymes acquires enzyme business from Iogen
7:01 AM MST | February 1, 2013 | Deepti Ramesh
Novozymes says it will acquire Iogen Bio-Products, the industrial enzyme business of Iogen (Ottawa, ON) for C$67.5 million ($67.6 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities, and know-how. The acquisition does not include the purchase of process technology assets that relate to Iogen’s second-generation biofuels business. The acquisition is expected to be completed by the end of this month. Iogen...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee